NCT00329576View on ClinicalTrials.gov

Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine

PHASE4CompletedINTERVENTIONAL

Enrollment

632

Participants

Timeline

Start Date

May 31, 2006

Study Completion Date

August 31, 2006

Conditions

Hepatitis B

Interventions

BIOLOGICAL

Hepatitis B vaccine

Trial Locations (3)

2610

GSK Investigational Site, Wilrijk

4002

GSK Investigational Site, Basel

80799

GSK Investigational Site, Munich

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00329576 - Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine | Biotech Hunter | Biotech Hunter